Protective Effects of Kaempferol on Lipopolysaccharide-Induced Mastitis in Mice

Inflammation

Volumn 37, Issue 5, 2014, Pages 1453-1458

  Cao, Rongfeng ^a,b   Fu, Kaiqiang ^b   Lv, Xiaopei ^b   Li, Weishi ^b   Zhang, Naisheng ^a  

^a JILIN UNIVERSITY   (China)

^b QINGDAO AGRICULTURAL UNIVERSITY   (China)

Author keywords

kaempferol; LPS; mastitis; NF B

Indexed keywords

I KAPPA B ALPHA; INTERLEUKIN 1BETA; INTERLEUKIN 6; KAEMPFEROL; LIPOPOLYSACCHARIDE; MYELOPEROXIDASE; TRANSCRIPTION FACTOR RELA; TUMOR NECROSIS FACTOR ALPHA; AUTACOID; KAEMPFEROL DERIVATIVE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIINFLAMMATORY ACTIVITY; ARTICLE; DRUG MECHANISM; ENZYME ACTIVATION; FEMALE; MALE; MASTITIS; MOUSE; NEUTROPHIL CHEMOTAXIS; NONHUMAN; PROTEIN DEGRADATION; PROTEIN PHOSPHORYLATION; ANIMAL; ANTAGONISTS AND INHIBITORS; BAGG ALBINO MOUSE; CHEMICALLY INDUCED; METABOLISM; RANDOMIZATION;

KAEMPFERIA GALANGA; MUS; ZINGIBERACEAE;

ANIMALS; FEMALE; INFLAMMATION MEDIATORS; KAEMPFEROLS; LIPOPOLYSACCHARIDES; MALE; MASTITIS; MICE; MICE, INBRED BALB C; RANDOM ALLOCATION;

EID: 84918815015     PISSN: 03603997     EISSN: 15732576     Source Type: Journal    
DOI: 10.1007/s10753-014-9870-9     Document Type: Article

References (29)

1. Miller, G.Y., P.C. Bartlett, S.E. Lance, J. Anderson, and L.E. Heider. 1993. Costs of clinical mastitis and mastitis prevention in dairy herds. Journal of the American Veterinary Medical Association 202: 1230–6.
2. Halasa, T., K. Huijps, O. Osteras, and H. Hogeveen. 2007. Economic effects of bovine mastitis and mastitis management: a review. The Veterinary quarterly 29: 18–31.
3. Fonseca, I., P.V. Silva, C.C. Lange, M.F. Guimaraes, M.M. Weller, K.R. Sousa, et al. 2009. Expression profile of genes associated with mastitis in dairy cattle. Genetics and molecular biology 32: 776–81.
4. Hogan, J., and L.K. Smith. 2003. Coliform mastitis. Veterinary research 34: 507–19.
5. Ershun, Z., F. Yunhe, W. Zhengkai, C. Yongguo, Z. Naisheng, and Y. Zhengtao. 2013. Cepharanthine attenuates lipopolysaccharide-induced mice mastitis by suppressing the NF-kappaB signaling pathway. Inflammation 2: 331–7.
6. O'Neill, L.A., and C. Kaltschmidt. 1997. NF-kappa B: a crucial transcription factor for glial and neuronal cell function. Trends in neurosciences 20: 252–8.
7. Gillespie, B.E., H. Moorehead, P. Lunn, H.H. Dowlen, D.L. Johnson, K.C. Lamar, et al. 2002. Efficacy of extended pirlimycin hydrochloride therapy for treatment of environmental Streptococcus spp and Staphylococcus aureus intramammary infections in lactating dairy cows. Veterinary therapeutics: research in applied veterinary medicine 3: 373–80.
8. Vissiennon, C., K. Nieber, O. Kelber, and V. Butterweck. 2012. Route of administration determines the anxiolytic activity of the flavonols kaempferol, quercetin and myricetin—are they prodrugs? The Journal of nutritional biochemistry 23: 733–40.
9. Kim, H.K., H.R. Park, J.S. Lee, T.S. Chung, H.Y. Chung, and J. Chung. 2007. Down-regulation of iNOS and TNF-alpha expression by kaempferol via NF-kappaB inactivation in aged rat gingival tissues. Biogerontology 8: 399–408.
10. Li, D., N. Zhang, Y. Cao, W. Zhang, G. Su, Y. Sun, et al. 2013. Emodin ameliorates lipopolysaccharide-induced mastitis in mice by inhibiting activation of NF-kappaB and MAPKs signal pathways. European journal of pharmacology 705: 79–85.
11. Chen, X., X. Yang, T. Liu, M. Guan, X. Feng, W. Dong, et al. 2012. Kaempferol regulates MAPKs and NF-kappaB signaling pathways to attenuate LPS-induced acute lung injury in mice. International immunopharmacology 14: 209–16.
12. Quan, Z., Y.J. Lee, J.H. Yang, Y. Lu, Y. Li, Y.K. Lee, et al. 2010. Ethanol extracts of Saururus chinensis suppress ovalbumin-sensitization airway inflammation. Journal of Ethnopharmacology 132: 143–149.
13. Naruko, T., A. Furukawa, K. Yunoki, R. Komatsu, M. Nakagawa, Y. Matsumura, et al. 2010. Increased expression and plasma levels of myeloperoxidase are closely related to the presence of angiographically-detected complex lesion morphology in unstable angina. Heart 96: 1716–22.
14. Nussbaum, C., A. Klinke, M. Adam, S. Baldus, and M. Sperandio. 2013. Myeloperoxidase: a leukocyte-derived protagonist of inflammation and cardiovascular disease. Antioxidants & redox signaling 18: 692–713.
15. Riollet, C., P. Rainard, and B. Poutrel. 2001. Cell subpopulations and cytokine expression in cow milk in response to chronic Staphylococcus aureus infection. Journal of dairy science 84: 1077–84.
16. Vallabhapurapu, S., and M. Karin. 2009. Regulation and function of NF-kappaB transcription factors in the immune system. Annual review of immunology 27: 693–733.
17. Chang, R., Q. Yang, G. Liu, Y. Liu, B. Zheng, J. Su, et al. 2013. Treatment with gentamicin on a murine model of protothecal mastitis. Mycopathologia 175: 241–8.
18. Mahat, M.Y., N.M. Kulkarni, S.L. Vishwakarma, F.R. Khan, B.S. Thippeswamy, V. Hebballi, et al. 2010. Modulation of the cyclooxygenase pathway via inhibition of nitric oxide production contributes to the anti-inflammatory activity of kaempferol. European journal of pharmacology 642: 169–76.
19. Homme, M., N. Tateno, N. Miura, N. Ohno, and Y. Aratani. 2013. Myeloperoxidase deficiency in mice exacerbates lung inflammation induced by nonviable Candida albicans. Inflammation research: official journal of the European Histamine Research Society 62: 981–90 [et al].
20. Anatoliotakis, N., S. Deftereos, G. Bouras, G. Giannopoulos, D. Tsounis, C. Angelidis, et al. 2013. Myeloperoxidase: expressing inflammation and oxidative stress in cardiovascular disease. Current topics in medicinal chemistry 13: 115–38.
21. Satoh, H., G.S. Firestein, P.B. Billings, J.P. Harris, and E.M. Keithley. 2003. Proinflammatory cytokine expression in the endolymphatic sac during inner ear inflammation. Journal of the Association for Research in Otolaryngology: JARO 4: 139–47.
22. Balkwill, F. 2009. Tumour necrosis factor and cancer. Nature reviews Cancer 9: 361–71.
23. De Haij, S., A.C. Bakker, R.N. van der Geest, G. Haegeman, W. Vanden Berghe, J. Aarbiou, et al. 2005. NF-kappaB mediated IL-6 production by renal epithelial cells is regulated by c-jun NH2-terminal kinase. Journal of the American Society of Nephrology: JASN 16: 1603–11.
24. Dinarello, C.A. 2011. A clinical perspective of IL-1beta as the gatekeeper of inflammation. European journal of immunology 41: 1203–17.
25. Kimura, A., and T. Kishimoto. 2010. IL-6: regulator of Treg/Th17 balance. European journal of immunology 40: 1830–5.
26. Liaskou, E., D.V. Wilson, and Y.H. Oo. 2012. Innate immune cells in liver inflammation. Mediators of inflammation 2012: 949157.
27. Tak, P.P., and G.S. Firestein. 2001. NF-kappaB: a key role in inflammatory diseases. The Journal of clinical investigation 107: 7–11.
28. Baeuerle, P.A., and D. Baltimore. 1996. NF-kappa B: ten years after. Cell 87: 13–20.
29. Baker, R.G., M.S. Hayden, and S. Ghosh. 2011. NF-kappaB, inflammation, and metabolic disease. Cell metabolism 13: 11–22.